Back to the main directory
Industry / Sector Analysis / Equity
- EQUASENS - CA T1 : Pharmagest devient EQUASENS - Achat - Obj. 112,7 € - Pot. +50% by GreenSome Finance
- M2i - CA T1: +8,6% - Croissance interne forte pour 2022 - Opinion: Achat - Objectif: 6,92€ - Potentiel: +68,6% by GreenSome Finance
- Elliott Wave View: USDCAD Buyers in Control by Elliott Forecast
- Siemens AG: Q1 2022 Results by La Française
- Stock Smart Weekly (May 13, 2022) by AKD Securities Limited
- FFBL_1QCY22 Corporate Briefing Session, (AKD Off the Analyst's Desk Mar 12, 2022) by AKD Securities Limited
- Pakistan OMCs_OMC volumes increase by 33%YoY for Apr'22 (AKD Daily, May 10, 2022) by AKD Securities Limited
- KSE-100_Remains under pressure, (AKD Technical Daily May 09, 2022) by AKD Securities Limited
- Pakistan Autos_Seasonal decline in Ramazan by AKD Securities Limited
- Stock Smart Weekly (Apr 28, 2022) by AKD Securities Limited
- Pakistan Economy_Inflation to touch 13.0% in Apr'22, (AKD Daily, Apr 28, 2022) by AKD Securities Limited
- KSE-100_Declines by 284pts, (AKD Technical Daily by AKD Securities Limited
- KSE-100: Faces a volatile session, by AKD Securities Limited
- KSE-100_Faces a bullish session by AKD Securities Limited
- KSE-100_Hovering near 200-SMA by AKD Securities Limited
- Pakistan Fertilizer_Profitability to remain elevated by AKD Securities Limited
- KSE-100_Approaching towards 200-SMA by AKD Securities Limited
- KSE-100_Approaching near support zone by AKD Securities Limited
- MLCF_3QFY22 Unconsolidated EPS clocked in at PkR1.08 - In-line with expectations by AKD Securities Limited
- MLCF & ASTL_ Result Previews, by AKD Securities Limited
- Pakistan Textile_9MFY22 textile exports up 25.4%YoY, (AKD Daily, Apr 18, 2022) by AKD Securities Limited
- Stock Smart Weekly by AKD Securities Limited
- Breakfast Report - 16 May 2022 by Vetiva Capital Management
- IIF Research Comment englisch - Aspermont LImited - 16.05.22 by GBC AG
- IIF Research Comment englisch - Cardiol Therapeutics Inc. - 16.05.22 by GBC AG
- PROLOGUE - CA T1: +13,4% - Très bonne dynamique attendue pour 2022 - Opinion: Achat - Objectif: 0,60€ - Potentiel: +119% by GreenSome Finance
- NZDUSD Selling The Rallies At The Blue Box Area by Elliott Forecast
- Veolia Environnement SA: Q1 2022 Results by La Française
- KSE-100_High volatility is expected, (AKD Technical Daily May 16, 2022) by AKD Securities Limited
- KSE-100_Sharp recovery witnessed, (AKD Technical Daily May 13, 2022) by AKD Securities Limited
- KSE-100_Range bound activity witnessed, (AKD Technical Daily May 11, 2022) by AKD Securities Limited
- KSE-100_A Big black candle occurred ,(AKD Technical Daily May 10, 2022) by AKD Securities Limited
- Pakistan Technology_COEUS Pakistan IPO_Subscribe, (AKD Daily, May 06, 2022) by AKD Securities Limited
- KSE-100_Bounces from 50-SMA, (AKD Technical Daily May 06, 2022) by AKD Securities Limited
- PSO_3QFY22 unconsolidated EPS clocked in at PkR69.4 - Higher than expectation, (AKD Off the Analyst's Desk Apr 28, 2022) by AKD Securities Limited
- LUCK_3QFY22 unconsolidated EPS clocked in at PkR17.12 - Higher than expectation by AKD Securities Limited
- MUGHAL & NML_9MFY22E Result Previews, by AKD Securities Limited
- Pakistan Fertilizer_Mar'22 urea offtake rise 48%YoY, by AKD Securities Limited
- Pakistan Cement_Profitability to decline 53-14%YoY-QoQ for 3QFY22, (AKD Daily, Apr 25, 2022) by AKD Securities Limited
- Stock Smart Weekly by AKD Securities Limited
- Investment im Fokus- EPTI AB - 16.05.22 by GBC AG
- Pakistan Power_Historic high in power generation for March by AKD Securities Limited
- Pakistan Refinery_Near term profitability to remain strong by AKD Securities Limited
- KSE-100_Range bound activity is expected by AKD Securities Limited
- KSE-100_Faces a volatile session, by AKD Securities Limited
- KSE-100_Remains positive; upside likely by AKD Securities Limited
- EPCL & EFERT_1QCY22 Result Previews by AKD Securities Limited
- IIF Research Comment - Aspermont Limited - 16.05.22 by GBC AG
- IIF Research Comment - Cardiol Therapeutics Inc. - 16.05.22 by GBC AG
- IIF Research Comment - Defence Therapeutics Inc. - 16.05.22 by GBC AG